Full Paper
and AgClO4 (1.0 mg, 4.7 mmol) and after washing with 5% NaOH
and extraction with CH2Cl2, pure 9 was obtained (48.9 mg, 85%).
Due to the instability of complex 9, characterization was accom-
plished for the demetalated analogue 9l.
(300 MHz, CDCl3): d=6.92 (d, J=8.8 Hz, 2H), 6.84 (d, J=8.8 Hz,
2H), 6.35 (s, 1H), 4.77 (d, J=11.1 Hz, 2H), 4.55 (s, 1H), 3.78 (s, 3H),
2.69–2.46 (m, 2H), 2.28–2.07 (m, 2H), 2.00 (s, 3H), 1.78 (s, 3H),
1.53 ppm (td, J=13.4, J=3.0 Hz, 1H); 13C NMR (126 MHz, CDCl3):
d=199.9, 154.5, 152.7, 148.5, 132.8, 131.1, 118.4, 114.9, 109.4, 88.5,
78.3, 74.8, 55.9, 38.0, 36.4, 32.1, 21.3, 19.7 ppm; IR (ATR): n˜ =2962,
Complex 10
2091, 2051, 2019, 1504, 1259, 1211, 1090, 1031, 796, 750, 702 cmÀ1
;
Following the general procedure, from alkyne–cobalt complex 7a
(52.0 mg, 0.12 mmol), 4-chlorophenol (26.7 mg, 0.21 mmol), and
AgClO4 (1.0 mg, 5.2 mmol), and after SiO2 chromatography (hexane/
EtOAc 50:1), pure 10 was obtained (41.6 mg, 64%). Due to the in-
stability of complex 10, characterization was accomplished for the
demetalated analogue 10l.
HRMS (ESI): m/z calcd for C25H22Co2NaO8 [M+Na]+: 590.9871;
found: 590.9848.
Complex 18
Following the general procedure, from alkyne–cobalt complex 16a
(67.0 mg, 0.14 mmol), 3,5-dimethylphenol (34.0 mg, 0.28 mmol),
and AgClO4 (1.5 mg, 7.2 mmol), and after washing with 5% NaOH
and extraction with CH2Cl2, pure 18 was obtained (61.1 mg, 77%).
1H NMR (300 MHz, CDCl3): d=6.69–6.51 (m, 3H), 6.34 (s, 1H), 4.76
(d, J=10.6 Hz, 2H), 4.68 (brs, 1H), 2.64–2.48 (m, 2H), 2.29 (s, 6H),
2.26–2.14 (m, 2H), 1.96 (s, 3H), 1.77 (s, 3H), 1.59 ppm (td, J=13.7,
4.1 Hz, 1H); 13C NMR (75 MHz, CDCl3): d=199.8, 158.7, 148.5, 139.5,
132.8, 131.0, 123.0, 114.1, 109.4, 74.8, 72.3, 37.8, 36.5, 32.3, 21.6,
21.3, 19.6 ppm; HRMS (ESI): m/z calcd for C26H24Co2NaO7 [M+Na]+:
589.0084; found: 589.0062.
Complex 11
Following the general procedure, from alkyne–cobalt complex 7a
(61.0 mg, 0.12 mmol), estrone (64.8 mg, 0.24 mmol), and AgClO4
(1.2 mg, 6.0 mmol), and after SiO2 chromatography (hexane/EtOAc
50:1), pure 11 was obtained (24.0 mg, 26%). 1H NMR (300 MHz,
CDCl3): d=7.19 (d, J=8.6 Hz, 1H), 6.78–6.70 (m, 1H), 6.70–6.60 (m,
1H), 6.21–6.11 (m, 1H), 4.37 (s, 1H), 2.94–2.80 (m, 2H), 2.51 (dd, J=
18.3, 8.3 Hz, 1H), 2.44–1.91 (m, 8H), 1.81–1.41 (m, 8H), 1.04 (s, 6H),
0.91 (s, 3H), 0.28 (s, 6H), 0.16 ppm (s, 3H); 13C NMR (101 MHz,
CDCl3): d=221.2, 200.2, 156.9, 137.9, 137.3, 132.4, 128.5, 126.5,
116.7, 116.3, 81.0, 50.6, 48.2, 44.2, 38.5, 36.0, 34.5, 33.9, 31.7, 29.8,
28.9, 27.1, 26.7, 26.0, 21.7, 20.8, 14.0, 0.8 ppm; IR (ATR): n˜ =2926,
Complex 19
Following the general procedure, from alkyne–cobalt complex 16a
(83.0 mg, 0.18 mmol), estrone (97.0 mg, 0.36 mmol), and AgClO4
(1.8 mg, 9.0 mmol), and after SiO2 chromatography (hexane/EtOAc
40:1 to 20:1), pure 19 was obtained (15.0 mg, 12%). 1H NMR
(400 MHz, CDCl3): d=7.21 (d, J=8.6 Hz, 1H), 6.78 (dd, J=8.6,
2.6 Hz, 1H), 6.72 (d, J=2.6 Hz, 1H), 6.34 (s, 1H), 4.76 (d, J=15.5 Hz,
2H), 4.67 (s, 1H), 2.99–2.79 (m, 2H), 2.62–2.53 (m, 1H), 2.53–2.43
(m, 1H), 2.46–2.31 (m, 2H), 2.31–2.01 (m, 6H), 1.95 (s, 3H), 1.77 (s,
3H), 1.68–1.43 (m, 8H), 0.91 ppm (s, 3H); 13C NMR (101 MHz,
CDCl3): d=221.1, 200.0, 156.7, 148.5, 138.1, 132.7, 131.1, 126.6,
116.5, 113.7, 109.4, 88.5, 74.8, 50.5, 48.2, 44.2, 38.5, 38.0, 36.5, 36.0,
32.2, 31.7, 29.8, 26.7, 26.0, 21.7, 21.3, 19.6, 14.0 ppm; IR (ATR): n˜ =
2927, 2858, 2091, 2053, 2025, 1738, 1604, 1573, 1496, 1453, 1279,
1244, 1099, 1053, 1036, 1008 cmÀ1; HRMS (ESI): m/z calcd for
C36H36ClCo2O8 [M+Cl]À: 749.0768; found: 749.0834.
2086, 2047, 2018, 1740, 1605, 1496, 1263, 1250, 841, 733, 701 cmÀ1
;
HRMS (ESI): m/z calcd for C37H42ClCo2O8Si [M+Cl]À: 795.1001;
found: 795.1009.
Complex 14
Following the general procedure, from alkyne–cobalt complex 12a
(54.0 mg, 0.13 mmol), 4-methoxyphenol (32.0 mg, 0.26 mmol), and
AgClO4 (1.4 mg, 6.6 mmol), and after washing with 5% NaOH and
extraction with CH2Cl2, pure 14 was obtained (60.5 mg, 90%).
1H NMR (400 MHz, CDCl3): d=6.89 (d, J=9.1 Hz, 2H), 6.83 (d, J=
9.0 Hz, 2H), 6.25 (s, 1H), 6.20 (s, 1H), 4.71 (s, 1H), 3.77 (s, 3H),
2.45–2.20 (m, 2H), 2.06–1.91 (m, 2H), 1.91–1.68 ppm (m, 2H);
13C NMR (101 MHz, CDCl3): d=199.8, 154.3, 151.8, 138.9, 128.5,
118.1, 114.8, 73.4, 55.8, 31.2, 29.9, 28.3 ppm; IR (ATR): n˜ =2932,
2093, 2053, 2022, 1506, 1225, 1105, 1040, 824 cmÀ1; HRMS (ESI): m/
z calcd for C21H16Co2NaO8 [M+Na]+: 536.9401; found: 536.9397.
Complex 21a
Following the general procedure, from alkyne–cobalt complex 20A
(149.6 mg, 0.28 mmol), 4-methoxyphenol (69.5 mg, 0.56 mmol),
and AgClO4 (3.0 mg, 14.0 mmol), and after SiO2 chromatography
(hexane/EtOAc 80:1), pure 21a was obtained (92 mg, 51%).
1H NMR (300 MHz, CDCl3): d=6.84 (m, 4H), 6.20 (s, 1H), 4.78 (d, J=
7.6 Hz, 1H), 3.76 (s, 3H), 3.32 (t, J=5.3 Hz, 1H), 2.59–2.32 (m, 2H;
4axial), 2.17 (dd, J=14.7, 4.5 Hz, 1H), 2.07 (dd, J=10.0, 4.5 Hz, 1H),
1.92 (d, J=10.0 Hz, 1H), 1.38 (s, 3H), 0.74 (s, 3H), 0.32 ppm (s, 9H);
13C NMR (126 MHz, CDCl3): d=200.3, 154.8, 151.9, 146.3, 125.4,
120.0, 114.8, 97.7, 80.3, 76.4, 55.8, 46.2, 41.9, 40.5, 33.2, 26.9, 25.9,
22.1, 1.2 ppm; IR (ATR): n˜ =2934, 2084, 2046, 2017, 1505, 1248,
1222, 1039, 841 cmÀ1; HRMS (ESI): m/z calcd for C28H30Co2NaO8Si
[M+Na]+: 663.0266; found: 663.0286.
Complex 15
Following the general procedure, from alkyne–cobalt complex 13a
(52.0 mg, 0.09 mmol), 4-methoxyphenol (21.8 mg, 0.18 mmol), and
AgClO4 (0.9 mg, 4.5 mmol), 15 was obtained after several purifica-
tions by chromatography (42 mg, 77%). Due to instability of this
product, only characteristic NMR signals are given. 1H NMR
(300 MHz, CDCl3): d=7.74–7.63 (m, 1H), 7.62–7.53 (m, 2H), 7.39–
7.28 (m, 11 H), 6.97–6.83 (m, 3H), 6.82–6.65 (m, 4H), 6.41 (d, J=
9.3 Hz, 1H), 5.33 (d, J=9.5 Hz, 1H), 3.75 (s, 3H), 0.16 ppm (s, 9H);
13C NMR (75 MHz, CDCl3): d=199.8, 155.0, 142.1, 140.5, 133.9,
128.7, 128.6, 128.5, 128.1, 126.8, 120.0, 114.5, 80.2, 55.8, 0.6 ppm.
Complex 17
Complex 21b
Following the general procedure, from alkyne–cobalt complex 16a
(76.0 mg, 0.16 mmol), 4-methoxyphenol (40.0 mg, 0.32 mmol), and
AgClO4 (1.6 mg, 8.0 mmol), and after SiO2 chromatography (hexane/
EtOAc 60:1), pure 17 was obtained (71.4 mg, 78%). 1H NMR
Following the general procedure, from alkyne–cobalt complex 20B
(112.2 mg, 0.21 mmol), 4-methoxyphenol (52.0 mg, 0.42 mmol),
and AgClO4 (2.2 mg, 10.0 mmol), and after washing with 5% NaOH
and extraction with CH2Cl2, pure 21b was obtained (114.0 mg,
Chem. Eur. J. 2016, 22, 9015 – 9023
9021
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim